Scott Hafeman

Liposome-siRNA-Peptide Complexes Cross the Blood-Brain Barrier and Significantly Decrease PrPC on Neuronal Cells and PrPRES in Infected Cell Cultures

Bruce Pulford, Natalia I. Reim, Aimee Bell et al. · PLoS ONE · 2010 · 85 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Combination Chemotherapy with Continuous <scp>l</scp> -Asparaginase, Lomustine, and Prednisone for Relapsed Canine Lymphoma

Corey Saba, Scott Hafeman, David M. Vail et al. · Journal of Veterinary Internal Medicine · 2009 · 61 citations · Full text

Medicine, Veterinary Oncology, Veterinary Pharmacology +14

Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs

Scott Hafeman, Cheryl A. London, Robyn Elmslie et al. · Cancer Immunology Immunotherapy · 2009 · 46 citations · Full text

Medicine, Pharmacology, Veterinary Pharmacology +7

Liposomal clodronate treatment for tumour macrophage depletion in dogs with soft‐tissue sarcoma

Amanda Guth, Scott Hafeman, Robyn Elmslie et al. · Veterinary and Comparative Oncology · 2012 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16

Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells

Scott Hafeman, D. Varland, Steven Dow · Veterinary and Comparative Oncology · 2011 · 25 citations

Medicine, Oncology, Pharmacology +13